Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tibion was a medical technology company that developed the world's first wearable bionic leg designed for stroke rehabilitation and mobility assistance. The Tibion Bionic Leg is a battery-powered, wearable robotic device that provides power-assist to the knee, helping patients with hemiparesis or lower-extremity weakness regain their gait and balance. The technology utilizes sensors to detect the user's intent and provides assistance during the stance and swing phases of walking. Tibion's products were primarily used in clinical settings for physical therapy and neurorehabilitation. The company was acquired by AlterG in 2013, which integrated the bionic leg technology into its portfolio of mobility solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tibion.